Stockscreener 앱 받기
29.54
12.29%
-4.14
시간 외 거래:
30.08
0.54
+1.83%
Surrozen Inc 주식(SRZN)의 최신 뉴스
Surrozen Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Surrozen Price Target Raised to $54.00/Share From $44.00 by HC Wainwright & Co. - Moomoo
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation By Investing.com - Investing.com South Africa
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation - Investing.com
(SRZN) Risk Channels and Responsive Allocation - Stock Traders Daily
DME red flag in Merck Brunello phase III? Surrozen finishes rich - BioWorld News
SRZN Price Today: Surrozen, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
Crude Oil Rises Over 4%; Darden Earnings Miss Views - benzinga.com
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy - benzinga.com
Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone - Quiver Quantitative
SRZN Options Volatility — NASDAQ:SRZN - TradingView
SRZN Options Chain — NASDAQ:SRZN - TradingView
Two new option listings and eight option delistings on September 21st - TipRanks
Surrozen, Inc.(NasdaqCM: SRZN) added to S&P Global BMI Index - marketscreener.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge - Investing.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge By Investing.com - Investing.com Canada
(SRZN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Surrozen submits IND to FDA for DME therapeutic - Glance by Eyes On Eyecare
Surrozen at Cantor healthcare conference: eye drug strategy takes shape - Investing.com
Surrozen at Cantor healthcare conference: eye drug strategy takes shape By Investing.com - Investing.com Canada
Guggenheim Names Top Biotechnology Stock Pick By Investing.com - Investing.com India
Surrozen files SZN-8141 IND application for DME - BioWorld News
Guggenheim Names Top Biotechnology Stock Pick - Investing.com
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema - markets.businessinsider.com
Surrozen Files Investigational New Drug Application for SZN-8141 in Diabetic Macular Edema - marketscreener.com
Surrozen Inc. Warrant (SRZNW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewswire
Surrozen Inc. Warrant (SRZNW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Surrozen Inc. Warrant (SRZNW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Surrozen Inc. Warrant (SRZNW) Peer Comparison – Compare with Others - Value Research
William Blair Upgrades Surrozen (NASDAQ:SRZN) to "Strong-Buy" - MarketBeat
William Blair Initiates Surrozen at Outperform - marketscreener.com
William Blair initiates Surrozen stock with Outperform rating By Investing.com - Investing.com Canada
William Blair initiates Surrozen stock with Outperform rating - Investing.com
Surrozen (SRZN) Q2 2026 Results: Profit Per Share Clears Its Benchmark on the Day; Market Reaction - vinanet.vn
Guggenheim Names Top Stock Pick in Biotech Sector By Investing.com - Investing.com Nigeria
LifeSci Capital Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $46 - Moomoo
SRZN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers Strong Beat as Stage Remains Pre-Revenue - vinanet.vn
Braidwell group reports 3.9% Surrozen (SRZN) holding in amended 13G filing - Stock Titan
Surrozen (SRZN): Boxer Capital group discloses 8.9% ownership stake in 13G/A - Stock Titan
Liquidity Mapping Around (SRZN) Price Events - Stock Traders Daily
StemPoint Capital reports 5.0% Surrozen (SRZN) stake via shares and warrants - Stock Titan
Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts - simplywall.st
What is HC Wainwright's Estimate for Surrozen Q3 Earnings? - MarketBeat
Surrozen (SRZN): 5AM Ventures group reports 7.8% beneficial ownership stake - Stock Titan
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44 - TipRanks
HC Wainwright Reiterates "Buy" Rating for Surrozen (NASDAQ:SRZN) - MarketBeat
H.C. Wainwright reiterates Surrozen stock rating at buy, $44 target - Investing.com India
Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SRZN Q1 2026 Earnings: Wider-Than-Expected Loss Despite 18.39% Share RallyEarnings Acceleration Picks - dars.gov.et
Surrozen (SRZN) warrants expiring 2026 removed from Nasdaq listing - Stock Titan
Surrozen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Surrozen earnings beat by $0.88, revenue topped estimates - Investing.com Canada
3.06%
2.55%
자본화:
|
볼륨(24시간):